This report from Life Science Intelligence provides the latest market data for the Global Interventional Cardiology Devices Market. Information covered by this report includes:
The global market for interventional cardiology devices is expected to reach an estimated $8 billion in 2020 and is projected to increase at a CAGR (2020-2024) of 7.7%. Product segments covered by this report include coronary stents, coronary catheters (excluding diagnostic catheters), coronary guidewires, coronary introducers, intravascular ultrasound catheters, and coronary guide catheters.
This report covers the impact of COVID-19 on the interventional cardiology devices market, including a recent forecast from 2020 to 2024. COVID-19 has also impacted leading competitors, such as Abbott, Boston Scientific, Cardinal Health, Medtronic, Merit Medical, Terumo, and others. The report provides insights into trends, drivers, and limiters of the interventional cardiology devices market, as well as highlights potential opportunities.
The interventional cardiology market was severely impacted by the COVID-19 pandemic as a result of the postponement of non-critical interventional cardiology procedures. While the decline in interventional cardiology procedures in 2020 was substantial, procedure volumes are projected to return to pre-COVID-19 levels in 2021.
The market leaders, Abbot and Boston Scientific, account for a combined market share of approximately 60% of sales attributable to the global interventional cardiology devices market. Beyond the two major competitors, the interventional cardiology market is heavily saturated with several small and large medtech companies.